Status:
UNKNOWN
MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia
Lead Sponsor:
Yanri Wijayanti Subronto, MD, PhD,
Collaborating Sponsors:
London School of Hygiene and Tropical Medicine
Kirby Institute
Conditions:
Hiv
Syphilis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Elimination of mother-to-child-transmission (EMTCT) of HIV, syphilis and hepatitis B are key priorities in Indonesia, the fourth most populous country in the world. Despite national guidelines and str...
Detailed Description
Using a cluster-randomized design, we will evaluate the effectiveness, cost-effectiveness, acceptability, fidelity and reach of a multi-faceted Continuous Quality Improvement (CQI) intervention to imp...
Eligibility Criteria
Inclusion
- This is cluster randomized control trial that unit of analysis is health facility. The following are the eligibility criteria for health facilities to be included in the trial:
- Facility with at least 320 first antenatal care visits or registrations per year (based on previous year's data).
- Facility is not currently engaged in another quality improvement intervention or other health-related research.
- Facility expected to provide antenatal care services and HIV/syphilis/hepatitis B testing for the duration of the study.
- Facility recorded 30% or less coverage of HIV testing amongst pregnant women (based on previous year's data).
- Exclusion Criteria:
- • If any reason is stated by the facility manager for not implementing the intervention if allocated to the intervention arm. Examples of (non-exhaustive) reasons that would exclude the facility are as follows: refusal to participate because of workload concerns or high turnover of staff, etc.
- \- Facility does not consent to participate
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06058286
Start Date
October 1 2023
End Date
December 31 2024
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Healthcare Centre in Bandung city and Bogor district
Bandung City and Bogor District, West Java, Indonesia